Growing community of inventors

Montpellier, France

Olivier Finance

Average Co-Inventor Count = 14.01

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 5

Olivier FinanceLajos T Nagy (1 patent)Olivier FinanceKatalin Urban-Szabo (14 patents)Olivier FinanceEndre Mikus (1 patent)Olivier FinanceImre Bata (1 patent)Olivier FinanceKinga Boer (9 patents)Olivier FinanceSándor Bátori (1 patent)Olivier FinanceKatalin Urbán-Szabó (1 patent)Olivier FinanceZoltán Kapui (1 patent)Olivier FinanceLászló Balázs (1 patent)Olivier FinanceMária Balogh (1 patent)Olivier FinanceKinga Boér (1 patent)Olivier FinanceGeza Tímári (1 patent)Olivier FinanceZsuzsanna Szamosvölgyi (1 patent)Olivier FinancePeter Arányi (1 patent)Olivier FinanceGábor Szeleczky (1 patent)Olivier FinanceSándor Batori (0 patent)Olivier FinanceLászlö Balazs (0 patent)Olivier FinancePéter Aranyi (0 patent)Olivier FinanceGéza Timari (0 patent)Olivier FinanceOlivier Finance (1 patent)Lajos T NagyLajos T Nagy (48 patents)Katalin Urban-SzaboKatalin Urban-Szabo (14 patents)Endre MikusEndre Mikus (13 patents)Imre BataImre Bata (11 patents)Kinga BoerKinga Boer (9 patents)Sándor BátoriSándor Bátori (6 patents)Katalin Urbán-SzabóKatalin Urbán-Szabó (3 patents)Zoltán KapuiZoltán Kapui (3 patents)László BalázsLászló Balázs (3 patents)Mária BaloghMária Balogh (2 patents)Kinga BoérKinga Boér (2 patents)Geza TímáriGeza Tímári (2 patents)Zsuzsanna SzamosvölgyiZsuzsanna Szamosvölgyi (2 patents)Peter ArányiPeter Arányi (1 patent)Gábor SzeleczkyGábor Szeleczky (1 patent)Sándor BatoriSándor Batori (0 patent)Lászlö BalazsLászlö Balazs (0 patent)Péter AranyiPéter Aranyi (0 patent)Géza TimariGéza Timari (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Sanofi-aventis (1 from 389 patents)

2. Sanofi (1,455 patents)


1 patent:

1. 6969723 - Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/4/2026
Loading…